The Sample - Page 4


Conflicted?

A New York Times article examines a potential conflict of interest for some genetic counselors.

This Week in Modern Pathology

In Modern Pathology this week: stem cell subpopulations found in metastatic and primary breast cancer tumors, and more.

Good to Go

LabCorp purchase of Medtox cleared by the US Federal Trade Commission.

This Week in Clinical Chemistry

In Clinical Chemistry this week: long-range PCR and massively parallel sequencing of mitochondrial genomes, and more.

Two New Tests for Bacterial Infections

Tests from BD Diagnostics and Nanosphere get a nod from FDA.

This Week in the Journal of Molecular Diagnostics

In the Journal of Molecular Diagnostics this week: high-resolution melting protocol to screen for oncogene variants in thyroid nodules, and more.

App as Device?

NPR's All Things Considered looks into when an app is a medical device.

This Week in Experimental and Molecular Pathology

In Experimental and Molecular Pathology this week: an automated DNA/RNA isolation system for FFPE samples, and more.

CMV Load Detector Approved

The US Food and Drug Administration has approved a DNA test that evaluates cytomegalovirus load.

This Week in the Journal of Clinical Pathology

In the Journal of Clinical Pathology this week: assessing KRAS mutation status from biopsy and surgical resection specimens, and more.

This Week in Modern Pathology

In Modern Pathology this week: intratumoral HER2 heterogeneity in breast cancer, and more.

And Signed

US President Barack Obama signs the FDA user fee bill.

KRAS Mutation Test Approved

FDA approves Qiagen's KRAS assay.